Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

EU brings forward Pfizer/BioNTech COVID shot for younger children to Dec 13

WorldDec 01, 2021 09:21AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: People queue for vaccination against the coronavirus disease (COVID-19) outside a doctor's practice, in the district of Friedrichshain, Berlin, Germany December 1, 2021. REUTERS/Annegret Hilse/File Photo 2/2

By Andreas Rinke and Ludwig Burger

FRANKFURT (Reuters) -The European Union-wide rollout of Pfizer (NYSE:PFE) and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week earlier than previously planned, Germany's health ministry said on Wednesday.

"Given the current pandemic situation, this is good news for parents and children. Many are awaiting this eagerly," acting health minister Jens Spahn said in the statement.

Germany is due to receive 2.4 million doses for use as a two-dose regimen, the ministry said, adding it has commitment on the new date from the manufacturer.

Germany's regional health ministers on Monday agreed to prepare for the launch, with offerings such as family sections within vaccination centres.

A BioNTech spokesperson confirmed the earlier start, adding it was contingent on the production batch passing quality control checks early next week.

The rollout will be brought forward without an impact on agreed delivery volumes thanks to "a massive effort including weekend work" on the part of Pfizer and BioNTech staff, the company added.

It said that while BioNTech had been in discussions with the EU Commission about the pandemic situation, it had not received a direct request for faster delivery. An EU official confirmed that the Commission had not prompted the move.

The EU last week approved use of the low-dose vaccine version for five- to 11-year-olds, following authorisation in May to give the standard adult dosage to children 12 years and older.

Pent-up demand for a shot for the youngest has been palpable in some countries. In hard-hit Austria, where the government has reimposed a nationwide lockdown, some provinces have been vaccinating five to 11-year-old children with a lower dose of the adult vaccine even before the EU recommendation.

Denmark followed suit with that method on Sunday, saying there was no time to lose amid rising infections among the youngest.

Coronavirus is spreading faster in Europe than in other world regions, prompting a scramble to persuade non-vaccinated adults to get shots, to get a campaign for third booster doses off the ground and to inoculate children.

Uncertainty over Omicron, the highly contagious new variant first detected in South Africa, has added urgency to the fight against the pandemic on many fronts.

Recorded infections among school-age children in Germany have surged and have been about twice as high as the all-age average over the last few weeks.

Frequent testing in classrooms may be bringing more asymptomatic cases to light than in the overall population.

The United States started distributing the paediatric version of the Pfizer shot in early November, followed by Canada in mid-November.

EU brings forward Pfizer/BioNTech COVID shot for younger children to Dec 13
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email